A phase III, randomized, active-controlled, parallel-group clinical trial to study the efficacy and long-term safety of mometasone furoate / formoterol fumarate (MF/F, MK-0887A [SCH418131]), compared with mometasone furoate (MF, MK-0887 [SCH032088]), in children with persistent asthma
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 08 Aug 2017
At a glance
- Drugs Mometasone/formoterol (Primary) ; Mometasone; Prednisone; Salbutamol
- Indications Asthma
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 22 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 23 May 2016 Status changed from not yet recruiting to recruiting.
- 13 Apr 2016 Status changed from recruiting to not yet recruiting.